The "Lutetium Oxide (CAS 12032-20-1) Industry Research 2025: Global and Regional Market Trends 2019-2024 and Forecast to 2029" report has been added to ResearchAndMarkets.com's offering.This report on ...

New research confirms Lutetium-177-PSMA-617 is effective for advanced prostate cancer, even after Radium-223 treatment.

What's the story of our Moon's early history? Despite all we know about our closest natural satellite, scientists are still ...

Researchers explored how Pluvicto is used in the community and academic settings and when given by oncologists or urologists.

US President Donald Trump and officials of his administration are convinced that Ukraine has reserves of rare earth metals.

Real-world data support trial data on the use of lutetium-177 PSMA-617 in patients with PSMA-positive, metastatic castration-resistant prostate cancer.